SCRN3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 3.5527136788005E-15 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
1.22779997280276E-09 |
Normal-vs-Stage2 |
1.019570E-04 |
Normal-vs-Stage3 |
1.62581059726108E-12 |
Normal-vs-Stage4 |
1.62458935193399E-12 |
Stage1-vs-Stage2 |
5.637000E-01 |
Stage1-vs-Stage3 |
1.609310E-04 |
Stage1-vs-Stage4 |
1.97366999999948E-05 |
Stage2-vs-Stage3 |
7.666200E-02 |
Stage2-vs-Stage4 |
3.048400E-02 |
Stage3-vs-Stage4 |
4.262200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.35447209004269E-14 |
Normal-vs-AfricanAmerican |
6.52879972307119E-10 |
Normal-vs-Asian |
3.286600E-01 |
Caucasian-vs-AfricanAmerican |
1.944960E-01 |
Caucasian-vs-Asian |
3.851200E-01 |
AfricanAmerican-vs-Asian |
1.825990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.11022302462516E-16 |
Normal-vs-Female |
2.95570001807022E-09 |
Male-vs-Female |
1.912240E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.39360001106104E-09 |
Normal-vs-Age(41-60Yrs) |
9.00635122036419E-12 |
Normal-vs-Age(61-80Yrs) |
6.99440505513849E-15 |
Normal-vs-Age(81-100Yrs) |
1.081180E-03 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.416800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.607800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.428000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.589200E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.124600E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
8.152800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
9.897600E-03 |
Normal-vs-Grade 2 |
2.75050000553279E-08 |
Normal-vs-Grade 3 |
1.11022302462516E-15 |
Normal-vs-Grade 4 |
1.62447832963153E-12 |
Grade 1-vs-Grade 2 |
7.705200E-01 |
Grade 1-vs-Grade 3 |
1.325980E-01 |
Grade 1-vs-Grade 4 |
5.968900E-04 |
Grade 2-vs-Grade 3 |
4.181900E-03 |
Grade 2-vs-Grade 4 |
3.90510002112876E-09 |
Grade 3-vs-Grade 4 |
4.048800E-04 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
2.01069999999914E-05 |
Normal-vs-ccB subtype |
4.44089209850063E-16 |
ccA subtype-vs-ccB subtype |
4.01029999985703E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
6.34636787566478E-12 |
Normal-vs-N1 |
3.163700E-04 |
N0-vs-N1 |
1.450030E-01 |
|
|